CareDx Stock News

Investors need to pay close attention to CareDx (CDNA) stock based on the movements in the options market lately.

Investors need to pay close attention to CareDx (CDNA) stock based on the movements in the options market lately.

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 16.) * BioNTech SE - ADR (NASDAQ: BNTX) (announced eff

CareDx, Inc. (CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant pati

CareDx Inc (NASDAQ:CDNA) CEO Peter Maag sold 10,000 shares of the stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $17.39, for a total value of $17

CareDx Inc (NASDAQ:CDNA) shares dropped 13.9% on Wednesday . The company traded as low as $18.89 and last traded at $18.94, approximately 1,101,124 shares changed hands during mid-day trading. An incr

Charles Schwab Investment Management Inc. cut its holdings in shares of CareDx Inc (NASDAQ:CDNA) by 3.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Se

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo...

SOUTH SAN FRANCISCO, Calif., March 12, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leader in precision medicine company focused on the discovery, development, and commercialization.

Equities research analysts predict that CareDx Inc (NASDAQ:CDNA) will post $37.61 million in sales for the current quarter, according to Zacks Investment Research. Four analysts have made estimates fo

Barclays PLC raised its holdings in shares of CareDx Inc (NASDAQ:CDNA) by 98.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fi

Bank of Montreal Can raised its stake in CareDx Inc (NASDAQ:CDNA) by 158.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1